• Contact Us
PAVmed Inc. - Innovating at the speed of life. PAVmed Inc. - Innovating at the speed of life.
  • Home
  • Company
    • About Us
    • Business Model
    • Leadership
    • Board of Directors
    • Medical Advisory Board
    • Careers
  • Products
    • EsoCheck
    • EsoGuard
    • CarpX
    • PortIO
    • DisappEAR
    • Future Innovations
  • Investor Relations
  • Contact
PAVmed Inc. - Innovating at the speed of life.
  • Home
  • Company
    • About Us
    • Business Model
    • Leadership
    • Board of Directors
    • Medical Advisory Board
    • Careers
  • Products
    • EsoCheck
    • EsoGuard
    • CarpX
    • PortIO
    • DisappEAR
    • Future Innovations
  • Investor Relations
  • Contact

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • NASDAQ: PAVM
    • NASDAQ: PAVMZ
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Board Diversity Matrix
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts

Lucid Diagnostics to Participate in the LSI USA ’22 Emerging Medtech Summit

Mar 04, 2022 8:25am EST

PAVmed Subsidiary Lucid Diagnostics Launches LucidDx Labs to Accommodate EsoGuard Testing Growth

Mar 03, 2022 8:25am EST

PAVmed Appoints Shaun O’Neil as Chief Operating Officer

Feb 24, 2022 8:25am EST

Evernorth Executive and Healthcare Services Industry Leader Joan Harvey Named to PAVmed Board of Directors

Feb 15, 2022 8:25am EST

Lucid Diagnostics to Participate in a Fireside Chat at the BTIG MedTech Digital Health, Life Science, and Diagnostics Tools Conference

Feb 10, 2022 8:25am EST

PAVmed and Lucid Diagnostics Welcome New Full-Time Investor Relations Team

Jan 12, 2022 8:25am EST

Lucid Diagnostics to Participate in a Fireside Chat at the 24th Annual Needham Virtual Growth Conference

Jan 06, 2022 8:30am EST

PAVmed Subsidiary Lucid Diagnostics Launches EsoGuard Telemedicine Program in Partnership with UpScriptHealth

Dec 01, 2021 8:30am EST

PAVmed and Lucid Provide Business Update and Preliminary Third Quarter 2021 Financial Results

Nov 16, 2021 4:13pm EST

PAVmed Subsidiary Lucid Diagnostics Launches Next Phase of Lucid Test Centers

Nov 11, 2021 8:30am EST
RSS
  • Prev
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • ...23
    Next
    • Email Alerts
    • Tear Sheet
    • Contacts
    • RSS News Feed

    About PAVmed Inc.

    PAVmed Inc. (Nasdaq:PAVM) is a highly-differentiated, multi-product medical device company employing a unique and proven business model designed to advance products from concept to commercialization much more rapidly and with significantly less capital than the typical medical device company. This model enables us to pursue an expanding pipeline strategy with a view to enhancing and accelerating value creation.

    Follow Us

    PAVmed Inc

    One Grand Central Place, Suite 4600
    New York, NY 10165
    212-949-4319
    info@pavmed.com


    PAVmed Inc. - Innovating at the speed of life.
    © Copyright 2023. All Rights Reserved by PAVmed Inc. .
    • News
    • Contact
    • Privacy Policy
    For more information regarding the proposed terms of settlement of a pending class action lawsuit, please click here.